CMAP as an electrophysiological biomarker in spinal muscular atrophy: A systematic review.

Cesaroni CA, Pisanò G, Rizzi S, Pantani A, Frattini D, Fusco C

Open source

DOI
10.1016/j.neucli.2026.103214
Published
2026 Oct 24
Container
Neurophysiologie clinique = Clinical neurophysiology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.neucli.2026.103214,
  title = {CMAP as an electrophysiological biomarker in spinal muscular atrophy: A systematic review.},
  author = {Cesaroni CA and Pisanò G and Rizzi S and Pantani A and Frattini D and Fusco C},
  year = {2026},
  journal = {Neurophysiologie clinique = Clinical neurophysiology},
  doi = {10.1016/j.neucli.2026.103214},
  url = {https://doi.org/10.1016/j.neucli.2026.103214}
}

RIS

TY  - JOUR
TI  - CMAP as an electrophysiological biomarker in spinal muscular atrophy: A systematic review.
AU  - Cesaroni CA
AU  - Pisanò G
AU  - Rizzi S
AU  - Pantani A
AU  - Frattini D
AU  - Fusco C
PY  - 2026
JO  - Neurophysiologie clinique = Clinical neurophysiology
DO  - 10.1016/j.neucli.2026.103214
UR  - https://doi.org/10.1016/j.neucli.2026.103214
ER  - 

APA

CA, C., G, P., S, R., A, P., D, F., & C, F. (2026). CMAP as an electrophysiological biomarker in spinal muscular atrophy: A systematic review.. Neurophysiologie clinique = Clinical neurophysiology. https://doi.org/10.1016/j.neucli.2026.103214

Source records